UBS Group’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $99M | Buy |
528,954
+192,674
| +57% | +$35.4M | 0.01% | 1131 |
|
|
2026
Q1 | $63.5M | Sell |
336,280
-107,786
| -24% | -$22.7M | 0.01% | 1402 |
|
|
2025
Q4 | $88.2M | Sell |
444,066
-47,766
| -10% | -$9.65M | 0.01% | 1113 |
|
|
2025
Q3 | $99.9M | Buy |
491,832
+192,060
| +64% | +$34.1M | 0.02% | 1030 |
|
|
2025
Q2 | $52.8M | Sell |
299,772
-293,312
| -49% | -$44.2M | 0.01% | 1479 |
|
|
2025
Q1 | $79.8M | Buy |
593,084
+4,106
| +0.7% | +$541K | 0.01% | 1083 |
|
|
2024
Q4 | $74.3M | Buy |
588,978
+220,252
| +60% | +$32.7M | 0.01% | 1121 |
|
|
2024
Q3 | $61.3M | Sell |
368,726
-15,390
| -4% | -$2.33M | 0.01% | 1027 |
|
|
2024
Q2 | $51.1M | Buy |
384,116
+121,557
| +46% | +$14.6M | 0.01% | 1028 |
|
|
2024
Q1 | $27.6M | Buy |
262,559
+54,338
| +26% | +$4.88M | 0.01% | 1444 |
|
|
2023
Q4 | $15.7M | Sell |
208,221
-5,875
| -3% | -$372K | ﹤0.01% | 1755 |
|
|
2023
Q3 | $14.1M | Sell |
214,096
-13,264
| -6% | -$992K | ﹤0.01% | 1727 |
|
|
2023
Q2 | $18.5M | Buy |
227,360
+30,767
| +16% | +$2.19M | 0.01% | 1509 |
|
|
2023
Q1 | $11.7M | Sell |
196,593
-395,027
| -67% | -$22M | ﹤0.01% | 1780 |
|
|
2022
Q4 | $28.9M | Buy |
591,620
+391,708
| +196% | +$18.1M | 0.01% | 1161 |
|
|
2022
Q3 | $10.3M | Sell |
199,912
-20,267
| -9% | -$1.2M | ﹤0.01% | 1763 |
|
|
2022
Q2 | $11.6M | Sell |
220,179
-94,229
| -30% | -$6.56M | ﹤0.01% | 1702 |
|
|
2022
Q1 | $27M | Buy |
314,408
+62,467
| +25% | +$5.13M | 0.01% | 1220 |
|
|
2021
Q4 | $20.6M | Buy |
251,941
+26,816
| +12% | +$1.96M | 0.01% | 1562 |
|
|
2021
Q3 | $15M | Buy |
225,125
+26,166
| +13% | +$1.86M | ﹤0.01% | 1724 |
|
|
2021
Q2 | $13.3M | Sell |
198,959
-26,648
| -12% | -$1.65M | ﹤0.01% | 1803 |
|
|
2021
Q1 | $11.7M | Sell |
225,607
-22,811
| -9% | -$1.15M | ﹤0.01% | 1815 |
|
|
2020
Q4 | $9.92M | Buy |
248,418
+1,818
| +0.7% | +$58.7K | ﹤0.01% | 1853 |
|
|
2020
Q3 | $6.04M | Sell |
246,600
-163,777
| -40% | -$4.18M | ﹤0.01% | 2021 |
|
|
2020
Q2 | $7.43M | Buy |
410,377
+220,718
| +116% | +$4.35M | ﹤0.01% | 1744 |
|
|
2020
Q1 | $2.73M | Sell |
189,659
-113,087
| -37% | -$3.25M | ﹤0.01% | 2458 |
|
|
2019
Q4 | $11.5M | Buy |
302,746
+235,134
| +348% | +$7.04M | ﹤0.01% | 1829 |
|
|
2019
Q3 | $1.5M | Buy |
67,612
+123
| +0.2% | +$2.62K | ﹤0.01% | 3599 |
|
|
2019
Q2 | $1.4M | Sell |
67,489
-13,077
| -16% | -$301K | ﹤0.01% | 3460 |
|
|
2019
Q1 | $2.32M | Sell |
80,566
-59,685
| -43% | -$1.47M | ﹤0.01% | 2864 |
|
|
2018
Q4 | $2.4M | Sell |
140,251
-22,654
| -14% | -$548K | ﹤0.01% | 2855 |
|
|
2018
Q3 | $4.64M | Sell |
162,905
-116,081
| -42% | -$3.83M | ﹤0.01% | 2419 |
|
|
2018
Q2 | $9.37M | Buy |
278,986
+190,805
| +216% | +$5.93M | ﹤0.01% | 1817 |
|
|
2018
Q1 | $2.14M | Buy |
88,181
+10,426
| +13% | +$208K | ﹤0.01% | 3084 |
|
|
2017
Q4 | $1.18M | Sell |
77,755
-7,404
| -9% | -$104K | ﹤0.01% | 3646 |
|
|
2017
Q3 | $1.4M | Sell |
85,159
-793
| -0.9% | -$13.4K | ﹤0.01% | 3422 |
|
|
2017
Q2 | $1.66M | Sell |
85,952
-32,943
| -28% | -$575K | ﹤0.01% | 3172 |
|
|
2017
Q1 | $2.1M | Buy |
118,895
+20,414
| +21% | +$379K | ﹤0.01% | 2901 |
|
|
2016
Q4 | $1.46M | Sell |
98,481
-22,905
| -19% | -$411K | ﹤0.01% | 3205 |
|
|
2016
Q3 | $2.75M | Sell |
121,386
-17,015
| -12% | -$443K | ﹤0.01% | 2558 |
|
|
2016
Q2 | $3.83M | Buy |
138,401
+16,791
| +14% | +$496K | ﹤0.01% | 2194 |
|
|
2016
Q1 | $3.52M | Buy |
121,610
+39,012
| +47% | +$1.01M | ﹤0.01% | 2177 |
|
|
2015
Q4 | $2.5M | Sell |
82,598
-55,642
| -40% | -$1.83M | ﹤0.01% | 2596 |
|
|
2015
Q3 | $5.1M | Sell |
138,240
-63,583
| -32% | -$3.29M | ﹤0.01% | 1904 |
|
|
2015
Q2 | $11.7M | Buy |
201,823
+15,880
| +9% | +$811K | 0.01% | 1354 |
|
|
2015
Q1 | $9.21M | Buy |
185,943
+63,679
| +52% | +$2.98M | 0.01% | 1542 |
|
|
2014
Q4 | $6.2M | Buy |
+122,264
| New | +$6.39M | ﹤0.01% | 1900 |
|
Other funds holding THC
GCM
UBS Group's THC Position: Q2 2026 in Review
UBS Group increased its Tenet Healthcare (THC) stake by 57% in Q2 2026, buying an estimated $35.4M and bringing the position to 528,954 shares worth $99M. The position accounts for 0.01% of the portfolio, ranked #1131.
UBS Group first reported a position in THC in Q4 2014 and has held it in 47 quarters since. The position peaked at $99.9M in Q3 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.
- UBS Group held 528,954 shares of Tenet Healthcare worth $99M as of Q2 2026.
- UBS Group bought 192,674 Tenet Healthcare shares in Q2 2026, an estimated $35.4M.
- Tenet Healthcare made up 0.01% of UBS Group's portfolio in Q2 2026, its #1131 holding.
- UBS Group first reported a position in Tenet Healthcare in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Tenet Healthcare position peaked at $99.9M in Q3 2025.
- 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.